Balloon angioplasty in infants with aortic obstruction after the modified stage I Norwood procedure

Citation
M. Chessa et al., Balloon angioplasty in infants with aortic obstruction after the modified stage I Norwood procedure, AM HEART J, 140(2), 2000, pp. 227-231
Citations number
26
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
AMERICAN HEART JOURNAL
ISSN journal
00028703 → ACNP
Volume
140
Issue
2
Year of publication
2000
Pages
227 - 231
Database
ISI
SICI code
0002-8703(200008)140:2<227:BAIIWA>2.0.ZU;2-U
Abstract
Background The incidence of coarctation after stage I Norwood procedure var ies between 11% and 37%, and it contributes to late death after this operat ion. We describe the incidence and report the results of percutaneous ballo on angioplasty of neoaortic arch obstruction in patients after the modified Norwood procedure for hypoplastic left heart syndrome (HLHS). Methods During a period of 5 years, 136 patients (94 male, 42 female) under went a first stage modified Norwood procedure for HLHS. All 95 survivors (6 9.8%) underwent cardiac catheterization before the second stage. Neoaortic arch obstruction was diagnosed on documentation of a peak systolic gradient of >10 mm Hg across the arch associated with angiographic evidence of loca lized narrowing of the aortic lumen. Results Twenty-one (22.1.%) of the 95 survivors were documented to have neo aortic arch obstruction. Seventeen patients underwent percutaneous balloon angioplasty for the relief of the neoaortic arch obstruction. The predilata tion peak gradient across the arch was reduced significantly by angioplasty from 28.6 +/- 16.9 mm Hg (range 10 to 73 mm Hg) to 5.3 +/- 5.2 mm Hg (rang e 0 to 19 mm Hg) (P <.001). A final gradient <10 mm Hg or <70% of the start ing gradient was considered a success. Conclusion The absence of serious sequelae after the procedure or need for reintervention, as shown by our study, makes balloon angioplasty an effecti ve technique and the treatment of choice for the relief of recoarctation of the neoaortic arch in patients with staged palliation of HLHS.